FIELD: medicine.
SUBSTANCE: therapeutic compositions of the invention comprise the leukocidin protein and its E and/or D polypeptide and a pharmaceutically acceptable carrier. A method for immunizing a patient against Staphylococcus aureus infection comprises administering a composition for preventing and treating staphylococcus in an amount effective to immunize a patient against Staphylococcus aureus.
EFFECT: effective screening, treatment, and prevention of infections of staphylococcus aureus and related disorders.
21 cl, 6 dwg, 6 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INHIBITING LEUCOCIDIN ED TOXICITY OF STAPHYLOCOCCUS AUREUS IN INDIVIDUAL | 2012 |
|
RU2609650C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2677140C1 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR USE | 2018 |
|
RU2795545C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2644237C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
| IMMUNOGENIC COMPOSITION APPLICABLE FOR STAPHYLOCOCCUS VACCINATION | 2009 |
|
RU2521501C2 |
| COMPOSITIONS AND METHODS RELEVANT TO MUTANT TOXIN FROM CLOSTRIDIUM DIFFICILE | 2013 |
|
RU2630671C2 |
| ANTIBODIES AGAINST STAPHYLOCOCCUS AUREUS LEUKOTOXINS | 2019 |
|
RU2805969C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
